Schwab Officer Reports Multiple Sales Under 10b5-1 Plan
Rhea-AI Filing Summary
Paul V. Woolway, MD, Chief Banking Officer of Schwab Charles Corp (SCHW), reported multiple sales of company common stock on 10/01/2025. The Form 4 shows two Rule 10b5-1 plan sales of 1,913 and 1,292 shares (both marked S(1)) and another reported disposal of 25,153 shares. The reporting person states the sales were made under a Rule 10b5-1 trading plan adopted on November 15, 2024. Execution occurred in multiple trades at prices ranging from $92.49 to $94.25, with weighted average prices reported as $93.0449 and $93.7434. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Positive
- Sales were executed under a Rule 10b5-1 plan adopted on November 15, 2024
- Form 4 discloses weighted average prices and price ranges ($92.49–$94.25) and offers to provide full trade details upon request
- Form 4 was signed by an attorney-in-fact on 10/02/2025, indicating timely filing following the trades
Negative
- Reporting person disposed of 25,153 shares (plus separate sales of 1,913 and 1,292 shares) which reduces insider holdings
- Some ownership lines and totals in the table are ambiguous, requiring supplemental detail for precise post-transaction holdings
Insights
Insider sold shares under a pre-established 10b5-1 plan on 10/01/2025.
The filing documents sales of 1,913 and 1,292 shares executed in multiple trades and a listed disposal of 25,153 shares. The reporting person disclosed the plan adoption date as November 15, 2024, and provided weighted average sale prices of $93.0449 and $93.7434.
This matters because the filing shows the trades were pre-authorized under a Rule 10b5-1 plan, and the execution prices span $92.49–$94.25, details that are relevant to transaction timing and proceeds but do not, by themselves, disclose intent.
Filing confirms required disclosure and use of attorney-in-fact signature on 10/02/2025.
The Form 4 identifies the reporting person as an officer (MD, Chief Banking Officer) and includes an attorney-in-fact signature (P. Blake Allen), indicating the filing was executed promptly after the trades. The explanatory notes include price ranges and a willingness to provide full trade details on request.
That transparency fulfills Section 16 reporting mechanics; the filing contains explicit trade counts and price ranges but does not disclose proceeds or purpose of sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,913 | $93.0449 | $178K |
| Sale | Common Stock | 1,292 | $93.7434 | $121K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.
- F2. This transaction was executed in multiple trades at prices ranging from $92.49 to $93.44. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $93.54 to $94.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
AI-generated analysis. How Rhea-AI works. Not financial advice.
